Active Ingredient History
Beclometasone or beclomethasone, also known as beclomethasone dipropionate, and sold under the brand name Qvar among others, is a steroid medication. It is available as an inhaler, cream, pills, and nasal spray. The inhaled form is used in the long-term management of asthma. The cream may be used for dermatitis and psoriasis. The pills have been used to treat ulcerative colitis. The nasal spray is used to treat allergic rhinitis and nasal polyps. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Airway Management (Phase 4)
Anesthesia, Endotracheal (Phase 4)
Asthma ()
Breast Neoplasms (Phase 1/Phase 2)
Bronchial Diseases (Phase 2)
Bronchial Spasm (Phase 4)
Bronchiectasis (Phase 3)
Bronchopulmonary Dysplasia (Phase 3)
Burkitt Lymphoma (Phase 2)
COVID-19 (Phase 2)
Croup (Phase 3)
Dyspnea (Phase 4)
Emphysema (Phase 4)
Eosinophilic Esophagitis (Phase 1)
Folliculitis (Phase 2/Phase 3)
Gestational Trophoblastic Disease (Phase 1/Phase 2)
Graft vs Host Disease (Phase 3)
Healthy Volunteers (Phase 1)
HIV (Phase 1)
HIV Infections (Phase 2)
Hodgkin Disease (Phase 2)
Hyaline Membrane Disease (Phase 3)
Idiopathic Pulmonary Fibrosis (Phase 2)
Intestinal Neoplasms (Phase 3)
Kidney Neoplasms (Phase 1/Phase 2)
Leukemia (Phase 1/Phase 2)
Leukemia, Eosinophilic, Acute (Phase 2)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 4)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Neutrophilic, Chronic (Phase 2)
Lung Diseases (Phase 3)
Lung Transplantation (Phase 1/Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphomatoid Granulomatosis (Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Nasal Polyps (Phase 2)
Neuroblastoma (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 1/Phase 2)
Pharmacokinetics (Phase 1)
Plasmacytoma (Phase 2)
Primary Myelofibrosis (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Respiratory Sounds (Phase 4)
Respiratory Tract Diseases (Phase 3)
Respiratory Tract Infections (Phase 4)
Rhinitis, Allergic (Phase 4)
Rhinitis, Allergic, Perennial (Phase 3)
Sezary Syndrome (Phase 2)
Signs and Symptoms, Respiratory (Phase 4)
Sinusitis (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Status Asthmaticus (Phase 4)
Testicular Neoplasms (Phase 1/Phase 2)
Thrombocythemia, Essential (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue